ID   YCC-3/TP
AC   CVCL_9659
DR   cancercelllines; CVCL_9659
DR   Wikidata; Q54995337
RX   PubMed=18922971;
CC   Population: Korean.
CC   Doubling time: 32 hours (PubMed=18922971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3148; TYMP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9657 ! YCC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
RX   PubMed=18922971; DOI=10.1158/1541-7786.MCR-08-0166;
RA   Yu E.J., Lee Y., Rha S.Y., Kim T.S., Chung H.C., Oh B.K., Yang W.I.,
RA   Noh S.H., Jeung H.-C.;
RT   "Angiogenic factor thymidine phosphorylase increases cancer cell
RT   invasion activity in patients with gastric adenocarcinoma.";
RL   Mol. Cancer Res. 6:1554-1566(2008).
//